Workflow
Westlake (WLK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
WLKWestlake(WLK) ZACKS·2025-02-19 15:20

Core Viewpoint - Westlake Chemical (WLK) is expected to report quarterly earnings of 1.04pershare,reflectinga44.41.04 per share, reflecting a 44.4% increase year-over-year, with revenues projected at 2.89 billion, a 2.4% increase from the previous year [1]. Earnings Estimates - The consensus EPS estimate for the quarter has been revised upward by 0.9% over the past 30 days, indicating analysts' reassessment of their projections [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock performance [3]. Revenue Projections - Analysts predict 'Net external sales- Performance and Essential Materials' will reach 1.88billion,a0.11.88 billion, a 0.1% increase from the prior year [5]. - The consensus for 'Net external sales- Housing and Infrastructure Products' is estimated at 986.27 million, reflecting a 4.3% increase year-over-year [5]. - For 'Net external sales- Housing and Infrastructure Products- Housing Products', the estimate stands at 827.85million,indicatinga4.1827.85 million, indicating a 4.1% year-over-year change [6]. - 'Net external sales- Performance and Essential Materials- Essential Materials' is projected at 826.41 million, showing a 6.9% increase from the previous year [6]. - 'Net external sales- Housing and Infrastructure Products- Infrastructure Products' is expected to reach 151.67million,a0.4151.67 million, a 0.4% increase year-over-year [7]. - 'Net external sales- Performance and Essential Materials- Performance Materials' is estimated at 1.15 billion, reflecting a 3.5% increase from the prior year [7]. EBITDA Estimates - The consensus estimate for 'EBITDA- Housing and Infrastructure Products' is projected at 150.48million,downfrom150.48 million, down from 173 million in the previous year [8]. Stock Performance - Westlake shares have decreased by 2.3% over the past month, contrasting with a 4.7% increase in the Zacks S&P 500 composite, and the company holds a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [8].